Overview of Dr. Migdady
Yazan Migdady, MD is a quadruple board-certified, fellowship-trained hematologist/oncologist with special interest in the treatment of leukemia and hematological malignancies, especially allogenic (donor) bone marrow transplant and novel cellular therapy treatment.
Dr. Migdady graduated with honors from the Jordan University of Science and Technology. He then relocated to Houston, TX where he attended Baylor College of Medicine as a post-doctoral associate at the Lester and Sue Smith Breast Center. Dr. Migdady then went to Alpert Medical School of Brown University in Rhode Island where he completed an internal medicine residency program. He furthered his studies with a Master of Science in medical sciences (MSc) at the University of Florida in Gainesville, FL. From there, he completed a transfusion medicine fellowship at Stanford in Palo Alto, CA and then a hematology and oncology fellowship at the National Institutes of Health in Bethesda, MD (National Cancer Institute (NCI)/National Health, Lung and Blood Institute (NHLBI))
Today, Dr. Migdady is committed to both continued excellence in clinical practice and ongoing innovation through research. He is specifically interested in optimizing transplant therapies, increasing access to novel therapies and advancing the field of medicine.
Office
1721 E 19th Ave Ste 200
Denver, CO 80218
Education & Training
- Rhode Island HospitalResidency, 2010 - 2013
- Jordan University of Science and Technology FOMClass of 2007
Certifications & Licensure
- CO State Medical License 2023 - 2025
- FL State Medical License 2013 - 2025
- OR State Medical License 2021 - 2025
- WA State Medical License 2022 - 2025
- CA State Medical License 2016 - 2024
- RI State Medical License 2010 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- 49 citationsAcute myeloid leukemia in the vascular nicheChristopher R. Cogle, Raphael C. Bosse, Takae M. Brewer, Yazan Migdady, Reza Shirzad
Cancer Letters. 2016-10-01 - 9 citationsThe Novel Immunotherapeutic Oligodeoxynucleotide IMT504 Protects Neutropenic Animals from Fatal Pseudomonas aeruginosa Bacteremia and SepsisAbdullah Chahin, Steven M. Opal, Jorge Zorzopulos, David V. Jobes, Yazan Migdady
Antimicrobial Agents and Chemotherapy. 2015-02-01 - 36 citationsTransfusion-Associated Circulatory Overload: A Clinical Perspective.Joachim J. Bosboom, Robert B. Klanderman, Yazan Migdady, Barbara Bolhuis, Denise P. Veelo
Transfusion Medicine Reviews. 2019-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: